JAG1

protein-coding

jagged canonical Notch ligand 1, the group of MicroRNA protein coding host genes|CD molecules

Gene summary

The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]

Previous symbols:
  • AGS
  • JAGL1

MANE transcript

NM_000214.3

Inheritance

AD

ClinVar variants

P:548U:1219B:639

Top phenotype

Alagille syndrome; Deafness, congenital heart defects, and posterior embryotoxon

gnomAD constraint

pLI —, LoF o/e 0.06

Max pathogenic AF

—

Genomic locus

chr20:10,637,684-10,673,999

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~36.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Charcot-Marie-Tooth disease, axonal, Type 2HHSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0030458

Submitter: PanelApp Australia

Charcot-Marie-Tooth disease, axonal, Type 2HHSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0030458

Submitter: Labcorp Genetics (formerly Invitae)

Charcot-Marie-Tooth disease, axonal, Type 2HHLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0030458

Submitter: Ambry Genetics

Alagille syndrome due to a JAG1 point mutationDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0016862

Submitter: ClinGen

*JAG1* was first reported in relation to autosomal dominant Alagille syndrome in 1997 (Oda et al., PMID: 9207787). Alagille syndrome is an autosomal dominant disorder characterized by a paucity of intrahepatic bile ducts, in association with five main clinical abnormalities: cholestasis, cardiac disease, skeletal abnormalities, ocular abnormalities, and a characteristic facial phenotype. About 39% of patients also have renal involvement, mainly renal dysplasia (Kamath et al. 2012, PMID: 22105858). Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, the following disease entities, Alagille syndrome 1 (MIM:118450), Tetralogy of Fallot (MIM:187500), and Deafness, congenital heart defects, and posterior embryotoxon (MIM: 617992) have been lumped into one disease entity, “Alagille syndrome - *JAG1*.” Additionally, we found differences in molecular mechanism and phenotypic variability between Alagille syndrome and Charcot-Marie-Tooth disease, axonal, type 2HH, and the split curation for autosomal dominant Charcot-Marie-Tooth disease, axonal, type 2HH will be completed by a different GCEP. Probands harboring *JAG1* variants who present with isolated chronic kidney diseases, such as autosomal dominant tubulointerstitial kidney disease (ADTKD) (PMID: 41061854), glomerular disease, and cystic kidney disease (PMID: 38972501), have been reported. It is unclear at this time if these isolated phenotypes should be considered a part of the Alagille spectrum, or as independent disease entities, due to a lack of understanding of the mechanism and/or difficulty in retro-phenotyping probands for subtle features of the syndrome. While further research is needed to understand this complexity, it is recommended that *JAG1* be considered in genetic screening for renal disease. Six frameshift, four nonsense, three intronic, and two missense variants that have been reported in fifteen probands in seven publications (PMIDs: 6447191, 9207787, 12022040, 27967296, 33008311, 34746741, 37511516) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be haploinsufficiency. This gene-disease relationship is also supported by functional alteration in non-patient cells, expression studies, biochemical function, and a mouse model (PMIDs: 20437614, 29956768, 29449451, 30226866, 29162437). In summary, there is definitive evidence supporting the relationship between *JAG1* and autosomal dominant Alagille syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date April 14th, 2025 (SOP Version 11).

Alagille syndrome due to a JAG1 point mutationSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0016862

Submitter: PanelApp Australia

Alagille syndrome due to a JAG1 point mutationDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0016862

Submitter: G2P

Alagille syndrome due to a JAG1 point mutationSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0016862

Submitter: Labcorp Genetics (formerly Invitae)

Alagille syndrome due to a JAG1 point mutationDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0016862

Submitter: Ambry Genetics

tetralogy of fallotSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0008542

Submitter: Orphanet

Clinical Genomic Database (CGD)

Alagille syndrome; Deafness, congenital heart defects, and posterior embryotoxonAD

Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal

Intervention: Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Renal

Rationale: For Alagille syndrome, individuals may have hepatic complications, and medications (eg, ursodeoxycholic acid, cholestyramine), and, when necessary, partial external biliary diversion may be beneficial; Other treatments, such as fat-soluble vitamin supplementation may be beneficial; Surveillance for other manifestations, including cardiac and renal manifestations, may be beneficial in order to allow early diagnosis and treatment and/or preventive measures; Contact sports should be avoided; For Deafness, congenital heart defects, and posterior embryotoxon, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development

Comments: Liver transplantation has been described

Refs: 803282; 9039994; 9207788; 9207787; 9585603; 9700188; 9890073; 10590916; 10213047; 11152664; 11313761; 11511567; 11139239; 12022040; 12244552; 12239725; 12509572; 14993126; 16013021; 16573599; 17286312; 19597493; 19948535; 20301450; 20437614; 22040217; 22105858; 22488849; 22521120; 22759690; 22937766; 23752887; 23801938; 23956173; 32065591Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to JAG1 variants in ClinVar

27 Conditions Cataloged
Alagille syndrome due to a JAG1 point mutationTotal: 1582
Cardiovascular phenotypeTotal: 659
not providedTotal: 626
JAG1-related disorderTotal: 411
not specifiedTotal: 260
Tetralogy of FallotTotal: 232
Charcot-Marie-Tooth disease, axonal, Type 2HHTotal: 222
Deafness, congenital heart defects, and posterior embryotoxonTotal: 221

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000214.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
53
clinvar
428
clinvar
5
clinvar
486
missense
10
clinvar
45
clinvar
1151
clinvar
199
clinvar
7
clinvar
1412
nonsense
106
clinvar
31
clinvar
3
clinvar
140
start loss
1
clinvar
4
clinvar
5
frameshift
206
clinvar
84
clinvar
5
clinvar
295
splice donor/acceptor (+/-2bp)
25
clinvar
36
clinvar
7
clinvar
68
Total3482001219627122406

Highest pathogenic variant AF is 0.000006572807

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 16 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000214.3RefSeqNP_000205.126MANE Select
ENST00000254958.10EnsemblENSP00000254958.426MANE Select
ENST00000613518.1EnsemblENSP00000481034.13Standard
ENST00000622545.1EnsemblENSP00000484139.14Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
jag1bDanio rerio

Structure: pillar of the lateral semicircular canal

Quality: increased thickness

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Breast cancer - Homo sapiens (human)
  • TNF signaling pathway - Homo sapiens (human)
  • Apelin signaling pathway - Homo sapiens (human)
  • Th1 and Th2 cell differentiation - Homo sapiens (human)
  • Pathways in cancer - Homo sapiens (human)

Biological Process

  • angiogenesis
  • cell fate determination
  • negative regulation of cell-matrix adhesion
  • blood vessel remodeling
  • morphogenesis of an epithelial sheet

Molecular Function

  • Notch binding
  • structural molecule activity
  • calcium ion binding
  • protein binding
  • phospholipid binding

Cellular Component

  • extracellular region
  • plasma membrane
  • integral component of plasma membrane
  • adherens junction
  • membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000254958
Coding exons
26
Length
36363
Individuals with no LoFs
125740
Homozygous LoFs
0
Heterozygous LoFs
7
Defined
125747
p
0.0000278
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.254556960.6540.00004268128
Missense (PolyPhen)1102860.384623349
Synonymous0.1262742770.9900.00001972158
Loss of Function6.88462.80.06370.00000330772

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000440.000035rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Ligand for multiple Notch receptors and involved in the mediation of Notch signaling (PubMed:18660822, PubMed:20437614). May be involved in cell-fate decisions during hematopoiesis (PubMed:9462510). Seems to be involved in early and late stages of mammalian cardiovascular development. Inhibits myoblast differentiation (By similarity). Enhances fibroblast growth factor-induced angiogenesis (in vitro). {ECO:0000250, ECO:0000269|PubMed:18660822, ECO:0000269|PubMed:20437614, ECO:0000269|PubMed:9462510}.;
Disease
DISEASE: Alagille syndrome 1 (ALGS1) [MIM:118450]: A form of Alagille syndrome, an autosomal dominant multisystem disorder. It is clinically defined by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems. {ECO:0000269|PubMed:10220506, ECO:0000269|PubMed:10533065, ECO:0000269|PubMed:11058898, ECO:0000269|PubMed:11139247, ECO:0000269|PubMed:11157803, ECO:0000269|PubMed:11180599, ECO:0000269|PubMed:12442286, ECO:0000269|PubMed:12497640, ECO:0000269|PubMed:15712272, ECO:0000269|PubMed:16575836, ECO:0000269|PubMed:20437614, ECO:0000269|PubMed:23801938, ECO:0000269|PubMed:9207788, ECO:0000269|PubMed:9585603}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:11152664, ECO:0000269|PubMed:20437614}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, congenital heart defects, and posterior embryotoxon (DCHE) [MIM:617992]: An autosomal dominant disease characterized by mild to severe combined hearing loss, congenital heart defects, and posterior embryotoxon, a corneal abnormality consisting of a central collagen core surrounded by a thin layer of Descemets membrane and separated from the anterior chamber by a layer of endothelium. Congenital heart defects include tetralogy of Fallot, ventricular septal defect, or isolated peripheral pulmonic stenosis. {ECO:0000269|PubMed:12022040, ECO:0000269|PubMed:20437614}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.705

Intolerance Scores

LoFtool
0.00627
RVIS EVS
-2.14
RVIS percentile EVS
1.49

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Indispensability pred.
E
Indispensability score
0.983

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.